Stem/progenitor cells in mouse mammary gland development and breast cancer - PubMed (original) (raw)

Review

Stem/progenitor cells in mouse mammary gland development and breast cancer

Yi Li et al. J Mammary Gland Biol Neoplasia. 2005 Jan.

Abstract

Breast cancer is a genetically and clinically heterogeneous disease. It is unclear whether different target cells contribute to this heterogeneity and which cell types are most susceptible to oncogenesis. Stem cells are speculated to be the cellular origin of at least a subset of human breast cancers. To begin to address these issues, we have isolated and characterized cell populations enriched in normal mammary stem/progenitors and have studied the expression of putative stem/progenitor markers in tumors derived from genetically engineered mice. Specifically, transgenic activation of Wnt signaling in the mammary gland induces tumors comprised of epithelial and myoepithelial cells harboring the same genetic defect implying that the tumor arose from transformation of a bipotent progenitor cell. On the other hand, transgenic activation of Neu signaling induces tumors comprising cells of more limited lineage capacity. Thus, the heterogeneity of different breast cancers may reflect the activation of different oncogenic pathways, different cellular targets in which these genetic changes occur, or both.

PubMed Disclaimer

Similar articles

• Evidence that transgenes encoding components of the Wnt signaling pathway preferentially induce mammary cancers from progenitor cells.
  Li Y, Welm B, Podsypanina K, Huang S, Chamorro M, Zhang X, Rowlands T, Egeblad M, Cowin P, Werb Z, Tan LK, Rosen JM, Varmus HE. Li Y, et al. Proc Natl Acad Sci U S A. 2003 Dec 23;100(26):15853-8. doi: 10.1073/pnas.2136825100. Epub 2003 Dec 10. Proc Natl Acad Sci U S A. 2003. PMID: 14668450 Free PMC article.
• Wnt signaling, stem cells, and the cellular origin of breast cancer.
  Lindvall C, Bu W, Williams BO, Li Y. Lindvall C, et al. Stem Cell Rev. 2007 Jun;3(2):157-68. doi: 10.1007/s12015-007-0025-3. Stem Cell Rev. 2007. PMID: 17873348 Review.
• Transcription factor regulatory networks in mammary epithelial development and tumorigenesis.
  Siegel PM, Muller WJ. Siegel PM, et al. Oncogene. 2010 May 13;29(19):2753-9. doi: 10.1038/onc.2010.43. Epub 2010 Mar 29. Oncogene. 2010. PMID: 20348953 Review.
• IGF1R constitutive activation expands luminal progenitors and influences lineage differentiation during breast tumorigenesis.
  Farabaugh SM, Litzenburger BC, Elangovan A, Pecar G, Walheim L, Atkinson JM, Lee AV. Farabaugh SM, et al. Dev Biol. 2020 Jul 1;463(1):77-87. doi: 10.1016/j.ydbio.2020.04.007. Epub 2020 May 4. Dev Biol. 2020. PMID: 32376245 Free PMC article.
• Stem Cells and the Differentiation Hierarchy in Mammary Gland Development.
  Fu NY, Nolan E, Lindeman GJ, Visvader JE. Fu NY, et al. Physiol Rev. 2020 Apr 1;100(2):489-523. doi: 10.1152/physrev.00040.2018. Epub 2019 Sep 20. Physiol Rev. 2020. PMID: 31539305 Review.

Cited by

• ETV6-NTRK3 fusion oncogene initiates breast cancer from committed mammary progenitors via activation of AP1 complex.
  Li Z, Tognon CE, Godinho FJ, Yasaitis L, Hock H, Herschkowitz JI, Lannon CL, Cho E, Kim SJ, Bronson RT, Perou CM, Sorensen PH, Orkin SH. Li Z, et al. Cancer Cell. 2007 Dec;12(6):542-58. doi: 10.1016/j.ccr.2007.11.012. Cancer Cell. 2007. PMID: 18068631 Free PMC article.
• Introduction of oncogenes into mammary glands in vivo with an avian retroviral vector initiates and promotes carcinogenesis in mouse models.
  Du Z, Podsypanina K, Huang S, McGrath A, Toneff MJ, Bogoslovskaia E, Zhang X, Moraes RC, Fluck M, Allred DC, Lewis MT, Varmus HE, Li Y. Du Z, et al. Proc Natl Acad Sci U S A. 2006 Nov 14;103(46):17396-401. doi: 10.1073/pnas.0608607103. Epub 2006 Nov 7. Proc Natl Acad Sci U S A. 2006. PMID: 17090666 Free PMC article.
• High-throughput profiling of histone post-translational modifications and chromatin modifying proteins by reverse phase protein array.
  Wang X, Shi Z, Lu HY, Kim JJ, Bu W, Villalobos JA, Perera DN, Jung SY, Wang T, Grimm SL, Taylor BC, Rajapakshe K, Park H, Wulfkuhle J, Young NL, Li Y, Coarfa C, Edwards DP, Huang S. Wang X, et al. J Proteomics. 2022 Jun 30;262:104596. doi: 10.1016/j.jprot.2022.104596. Epub 2022 Apr 27. J Proteomics. 2022. PMID: 35489683 Free PMC article.
• Cancer Stem and Progenitor-Like Cells as Pharmacological Targets in Breast Cancer Treatment.
  de Souza VB, Schenka AA. de Souza VB, et al. Breast Cancer (Auckl). 2015 Nov 12;9(Suppl 2):45-55. doi: 10.4137/BCBCR.S29427. eCollection 2015. Breast Cancer (Auckl). 2015. PMID: 26609237 Free PMC article. Review.
• Exploring the origins of the normal prostate and prostate cancer stem cell.
  Kasper S. Kasper S. Stem Cell Rev. 2008 Sep;4(3):193-201. doi: 10.1007/s12015-008-9033-1. Stem Cell Rev. 2008. PMID: 18563640 Free PMC article. Review.

References

1. 1. J Clin Oncol. 1989 Mar;7(3):355-66 - PubMed
2. 1. Breast Cancer Res. 2003;5(1):R1-8 - PubMed
3. 1. Nat Rev Cancer. 2004 Oct;4(10 ):814-9 - PubMed
4. 1. Exp Cell Res. 2004 Apr 15;295(1):79-90 - PubMed
5. 1. Curr Opin Hematol. 2004 Mar;11(2):88-94 - PubMed

Publication types

MeSH terms

LinkOut - more resources

• Full Text Sources

  • Ovid Technologies, Inc.
  • Springer

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information

• Molecular Biology Databases

  • Mouse Genome Informatics (MGI)

• Research Materials

  • NCI CPTC Antibody Characterization Program

• Miscellaneous

  • NCI CPTAC Assay Portal